azomycin has been researched along with iohexol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellano, I; Charles-Edwards, E; Clarke, P; Fisher, C; Harrington, K; Leach, M; Mears, D; Newbold, K; Nutting, C; Rhys-Evans, P; Sohaib, A | 1 |
| Barber, PR; Bell, A; Burke, M; Daley, FM; Finch, J; Goh, V; Hoskin, PJ; Kozarski, R; Mandeville, HC; Ng, QS; Pierce, G; Townsend, ER; Vojnovic, B | 1 |
2 other study(ies) available for azomycin and iohexol
| Article | Year |
|---|---|
An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer.
Topics: Aged; Biomarkers, Tumor; Carbonic Anhydrases; Cell Hypoxia; Contrast Media; Female; Head and Neck Neoplasms; Humans; Iohexol; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Statistics, Nonparametric; Tomography, Spiral Computed | 2009 |
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.
Topics: Aged; Biomarkers, Tumor; Blood Volume; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Humans; Hypoxia; Immunohistochemistry; Iohexol; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitroimidazoles; Prospective Studies; Radiation-Sensitizing Agents; Radiographic Image Interpretation, Computer-Assisted; Statistics, Nonparametric; Tomography, Spiral Computed | 2012 |